Efficacy and Safety of Tamsulosin/Solifenacin Combination Therapy in Patients With Voiding Symptoms and Moderate to Severe Storage Symptoms Due to Benign Prostate Hyperplasia
Clinical trial NCT02827578 · UNKNOWN
Trial details
- NCT number
- NCT02827578
- Sponsor
- IlDong Pharmaceutical Co Ltd
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2017-08-01
- Enrollment
- 588
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.